Drawing for CANON

USPTO serial 79436871

CANON

Reviewed by CopyMark Law Group

Reg. 8374775Status 700Registered
Filing date
Status date
Registration date
Aug 4, 2026
Examiner
MEBANE, ANASTASIA XAVIERA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CANON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dennis J. McMahon

Dennis J. McMahon Venable LLP151 West 42nd Street, 49th FloorNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
001Industrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical preparations for use in photography; chemical compositions for developing photographs; biological preparations for use in industry and science; plant growth regulating preparations; diagnostic reagents and preparations, other than for medical or veterinary purposes; reagents for scientific use; diagnostic reagents and preparations for scientific purposes; reagents for research purposes; protein in raw material form for scientific and medical research; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical test paper; reagent paper, other than for medical or veterinary purposes; chemicals, namely, standard solutions for use in analytical chemistry; chemical preparations in the nature of control samples for quality control testing; buffer solutions for use in analytical chemistry.ACTIVE—
005Pharmaceuticals, medical and veterinary preparations for diagnosing diabetes, dyslipidemia, kidney disease, heart disease, cancer and allergy; sanitary preparations for medical purposes; diagnostic reagents for medical purposes; chemical reagents for medical purposes; diagnostic preparations for medical purposes; reagents for medical purposes; blood plasma; reagent paper for medical purposes; allergy diagnostic test kits comprised of immunoassay reagents; in vitro allergy panel test kits for clinic and medical laboratory use consisting primarily of diagnostic reagents and allergen-coated solid supports for testing human serum; reagents for allergy diagnosis; diagnostic test kits for medical or veterinary purposes comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in detecting diseases, namely, diabetes, dyslipidemia, kidney disease, heart disease, and cancer; diagnostic test kits for medical or veterinary purposes consisting primarily of test strips and buffer solution for use in detection of fecal occult blood; pharmaceutical preparations for treating diabetes, dyslipidemia, kidney disease, heart disease, cancer and allergy; serums for use in diagnostic testing.ACTIVE—
010Surgical and medical apparatus and instruments in the nature of surgical apparatus and instruments, medical apparatus and instruments for diagnosis of diabetes, dyslipidemia, kidney disease, heart disease, cancer and allergy; diagnostic apparatus and instruments for medical purposes for measuring hemoglobin levels; diagnostic apparatus and instruments for medical purposes for in vitro hemoglobin measurement; medical apparatus and instruments for measurement of hemoglobin levels; sample preparation devices for medical diagnostic use; medical apparatus, namely automated biochemical analyzers; testing apparatus for medical purposes for measuring hemoglobin levels; blood testing apparatus; measuring apparatus and instruments for medical purposes, namely, measuring apparatus and instruments for measuring hemoglobin levels; diagnostic test kits consisting primarily of diagnostic apparatus and instruments, namely, test strips readers for use in detection of fecal occult blood; medical diagnostic instruments for the analysis of body fluids; apparatus for carrying out diagnostic tests for medical purposes; apparatus for clinical diagnosis; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical testing apparatus for use in the detection of fecal occult blood; medical test kits for detecting fecal occult blood primarily consisting of diagnostic apparatus for medical purposes; medical diagnostic apparatus for detecting fecal occult blood; allergy diagnostic equipment, namely, medical diagnostic apparatus for determining allergies; specimen samplers for medical purposes; feces sampling tools for medical use consisting of water-dispersible paper; containers especially adapted for the collection of fecal matter.ACTIVE—
044Medical services; provision of information, advice and consulting on medical and regenerative medicine services; human tissue bank services; provision of medical information; providing information relating to medical services; medical, medicinal and pharmaceutical consultancy; collection and preservation of human blood; medical laboratory services for the analysis of samples taken from patients; medical consultations; medical information; medical testing services; medical screening; medical diagnostic services, namely, testing and analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 4, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 4, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 16, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 21, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 10, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 10, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2026RFNTREFUSAL PROCESSED BY IB—
Jan 22, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 22, 2026RFRRREFUSAL PROCESSED BY MPU—
Dec 22, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 21, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 16, 2025DOCKASSIGNED TO EXAMINER—
Nov 14, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 14, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 13, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance